Cadila Healthcare to develop vaccines for ‘Congo Virus’ and ‘Ebola Virus’

31 Dec 2014 Evaluate

Cadila Healthcare is developing vaccines for ‘Congo Virus’ and ‘Ebola Virus’ as a part of Company's vaccine development programme. However, the company has not shared investment details.

Cadila Healthcare operates in areas of active pharmaceutical ingredients (API) to formulations, and animal health products to cosmeceuticals.

Zydus Lifesciences Share Price

916.55 -5.45 (-0.59%)
12-Mar-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1835.90
Dr. Reddys Lab 1315.10
Cipla 1323.05
Zydus Lifesciences 916.55
Lupin 2340.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×